Oct 26, 2021 | Drug Costs, Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the Build Back Better reconciliation bill currently being debated in Congress and highlight its drug pricing components. They explain how the highly-touted cost savings in the bill won’t actually help...
Read more
Sep 28, 2021 | Drug Costs
On September 9, 2021, the Biden Administration released a long-awaited plan aimed at reducing prescription drug prices. What’s in the Plan? At a high level, the plan would: Allow the Secretary of Health and Human Services (HHS) to negotiate Medicare Part B...
Read more
Oct 16, 2020 | Drug Costs
The debate over whether the rebate system that currently exists in the U.S. is beneficial for patients or payers or pharmacy benefit managers (PBMs) has been endless. Now, a new report from the Center for Medical Economics and Innovation at the Pacific Research...
Read more
Sep 24, 2020 | Drug Costs, State Issues
An international drug pricing model developed by the National Academy for State Health Policy has been proposed to be adopted in Pennsylvania to reduce drug costs in the state. Senator Tom Killion introduced the Prescription Drug Cost Reduction Act (Senate Bill 1315)...
Read more
Sep 16, 2020 | Drug Costs, Featured, Podcast
On this episode of the podcast, Terry and Bob discuss what goes into a drug price. They pull the curtain to reveal the group of middlemen between drugmakers and the patient that drives up the drug prices patients pay. They highlight the bizarre system of drug rebates,...
Read more
Aug 2, 2020 | Drug Costs, Featured, Podcast
On this week’s episode of the Patient’s Rising podcast, Terry and Bob discuss President Trump’s executive orders on prescription drug prices. Recently, Trump signed a series of Executive Orders that direct U.S. Health and Human Services to take steps...
Read more
